Tolterodine Tartrate Extended Release
Product Images NDC 59762-0047

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate Extended Release (NDC 59762-0047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tolterodine Er 01)

Chemical structure diagram of Tolterodine Tartrate, depicting the molecular components of the active ingredient in Tolterodine Tartrate Extended Release by Mylan Pharmaceuticals Inc.*

FDA Label Image

Logo (Tolterodine Er 02)

FDA Label Image

Principal Display Panel (2 mg Capsule Bottle Label)

Label for Tolterodine Tartrate Extended Release Capsules, 2 mg, containing 30 capsules. The product is a Greenstone brand distributed by Greenstone LLC. Storage instructions and a note about dosage and use are included. The label indicates the capsules are for prescription use only.*

FDA Label Image

Principal Display Panel (4 mg Capsule Bottle Label)

Label for Tolterodine Tartrate Extended Release capsules, 4 mg strength, containing 30 capsules. The product is branded as Greenstone and distributed by Greenstone LLC, Peapack, NJ. The label includes storage instructions, dosage and use notes, an NDC number 59762-0048-1, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.